Synvect is a biotech platform that creates safe and effective ways to eliminate disease-carrying mosquitoes by stopping their breeding.
Synvect has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in March 2025.
Synvect's investors include Antler, Bill & Melinda Gates Foundation, Redbud VC, NuFund Venture Group.
Synvect is headquartered in San Diego, United States.
Synvect is a biotech platform that creates safe and effective ways to eliminate disease-carrying mosquitoes by stopping their breeding.
Synvect is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Synvect — Funding & Investors." VCBacked, March 11, 2025, https://www.vcbacked.co/company/synvect. Accessed July 19, 2026.
VCBacked. (2025). Synvect — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/synvect
{{cite web |title=Synvect — Funding & Investors |url=https://www.vcbacked.co/company/synvect |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated